ACTS Connection

November 2021

Issue 1

Letter From the President

Collaboration is a key component of all clinical and translational science. It is a skill that needs to be learned and taught to our scholars. But it is also one of those lifelong skills that we need to continue to develop over time. At ACTS, we highly value and promote collaboration with our members, NIH and all other government agencies invested in clinical and translational research, industry and all institutions participating in this endeavor. 

Collaboration is a complex skill that includes the ability to form networks, connect with others and communicate effectively. We want ACTS to be the meeting place for clinical and translational research networks. Through our website, social media and events, ACTS provides spaces where different members of the clinical and translational research workforce can come together to improve the health and lives of people. Our goal as an association is to connect people who can work together to find answers to the tough questions on how to translate clinical findings into real world solutions. 

We have found that communication has been hard during these pandemic times. We are fortunate to have the tools to continue to meet through online platforms and meetings. But communication in a two-dimensional world is usually not enough for us humans. Our brain is wired to respond to physical proximity and to three-dimensional faces. Without in-person meetings, it is sometimes hard to follow if someone has received all the information needed to continue in a collaboration. This is one of the reasons why we think it is so important to have an in-person Translational Science Meeting in 2022. We expect everyone from the clinical and translational science community to join us in Chicago.

Another important skill to promote collaborations is active listening. ACTS is continuously seeking out your voice, your opinion, and your thoughts on all matters clinical and translational science. We have been listening to what our members want from us. We know you want to have the resources available to continue doing your work. We know you want to continue contributing to the health of your communities. We will continue to listen to all our members and all the stakeholders in the clinical and translational research effort and we will continue to build bridges that open new routes towards our end goal of improving health. 

Karen G. Martinez-Gonzalez, MD, MSc

ACTS President  

 

Translational Science 2022: Call for Poster Proposals

Translational Science: Transformational Translational Science: Opportunities for Success is still accepting poster proposals! Don't miss your chance to showcase your original research to an audience of key thought leaders.

Poster proposals are due Monday, November 29.  Please visit our website to learn more about the submissions portal, best practices, and more. We look forward to receiving your poster submissions!

 

Journal of Clinical and Translational Science: The Official Journal of ACTS and CR Forum

Share innovative advances in the translational science area to the global research community through JCTS!

  • Gold Open Access: fully compliant with Open Access Mandates
  • Articles funded by the NIH will be manually sent to PubMed Central
  • Articles appear with their final citation details as soon as they are published online
  • Prestigious editorial board listing
  • Global dissemination of your paper
  • MetricsAltmetrics and Kudos to monitor submissions

Want to receive alerts when new articles are published? Click the 'Add Alert' (🔔) icon here, then login or register for a Cambridge Core account to receive daily, weekly, or monthly updates.

Submit Your Research

 

August M. Watanabe Prize in Translational Research

Indiana University School of Medicine is pleased to award the August M. Watanabe Prize in Translational Research. The prize is one of the nation’s largest and most prestigious awards, recognizing individuals focused on shepherding scientific discoveries into new therapies for patients. The prize is awarded to a senior investigator who has made a significant contribution to the field of translational science. The winner will receive $100,000 and will spend September 14-16, 2022 in Indianapolis, as a vising dignitary, sharing insights and knowledge with audiences at IU School of Medicine and its partner institutions.

Nominees for the August M. Watanabe Prize in Translational Research should be members of the scientific or medical community who have demonstrated outstanding accomplishments in translational research.

The deadline for all nomination materials for the award is January 21, 2022. Any questions about the nomination process may be directed to amwprize@iu.edu or 317-278-2874.

 

Member Highlights

Do you know someone who deserves to be recognized for outstanding or groundbreaking work? Is your institution embarking on an exciting project? Send ACTS your story to be highlighted in future versions of ACTS Connection.

Submit stories here.

 

Career Center

The ACTS Career Center is the premier resource for connecting those in the field of translational science with career opportunities. Visit today to find a wealth of resources to help achieve your career goals.

ACTS members receive a 50% discount on the site—use code ACTSMEMBER to save!

Get Started

 

Translational Science Today

WVU Today | WVCTSI to steer 'medical clinic on wheels'...

A 39-foot customized Winnebago will serve as a medical clinic on wheels in even the most hard-to-reach areas of the state. By customizing and deploying a new mobile clinical trials unit, the West Virginia Clinical and Translational Science...
Read more
wvutoday.wvu.edu